DOD Biotech PCL (BKK:DOD)

Thailand · Delayed Price · Currency is THB

0.9800

-0.0100 (-1.01%)

Sep 3, 2026, 1:55 PM ICT

DOD Biotech PCL Financials Overview

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	543.07	621.21	662.04	692.71	548.33	1,018
Revenue Growth	-17.99%	-6.17%	-4.43%	26.33%	-46.16%	-5.70%
Gross Profit	177	222.3	223.46	286.35	151.68	437.65
Operating Income	-0.55	39.32	14.46	87.84	-11.38	309.3
Net Income	1.87	59.59	-159.33	7.19	-398.33	49.79
Earnings Per Share	0.00	0.13	-0.35	0.02	-0.97	0.12
EPS Growth	-96.16%	-	-	-	-	-64.45%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	110.35	290.02	223.09	67.99	30.27	161.68
Total Debt	67.65	70.35	46.06	168.69	229.08	183.3
Net Cash (Debt)	42.71	219.68	177.03	-100.7	-198.81	-21.62
Net Cash Growth	-78.98%	24.09%	-	-	-	-
Net Cash Per Share	0.09	0.49	0.39	-0.23	-0.48	-0.05

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-22.95	91.31	34.8	22.8	-130.71	145
Capital Expenditures	-81.69	-48.88	-22.49	-18.07	-63.29	-182.93
Free Cash Flow	-104.64	42.43	12.31	4.72	-194	-37.93
Free Cash Flow Growth	-	244.72%	160.59%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	32.59%	35.78%	33.75%	41.34%	27.66%	42.98%
Operating Margin	-0.10%	6.33%	2.18%	12.68%	-2.08%	30.37%
Pretax Margin	-0.89%	6.99%	6.12%	13.40%	-77.37%	26.03%
Profit Margin	0.34%	9.59%	-24.07%	1.04%	-72.65%	4.89%
FCF Margin	-19.27%	6.83%	1.86%	0.68%	-35.38%	-3.72%

Dividends

Fiscal Year	Current	FY 2025
Period Ending	Sep '26 Sep 3, 2026	Dec '25 Dec 31, 2025
Dividend Per Share	0.050	0.050
Dividend Per Share Growth	0%	-
Dividend Yield	5.10%	3.17%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	125.19	12.25	-	231.89	-	92.23
Forward PE	-	9.61	9.61	9.61	9.61	12.91
P/FCF Ratio	-	17.20	60.74	352.83	-	-
PS Ratio	0.82	1.18	1.13	2.41	3.26	4.51